- OHI has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $44.1 million.
- OHI has traded 789,460 shares today.
- OHI traded in a range 202% of the normal price range with a price range of $1.16.
- OHI traded below its daily resistance level (quality: 25 days, meaning that the stock is crossing a resistance level set by the last 25 calendar days. The resistance price is defined by the Price - $0.01 at the time of the signal).
Stocks matching the 'Water-Logged and Getting Wetter' criteria are worthwhile stocks to watch for a variety of factors including historical back testing and volatility. Trade-Ideas targets these opportunities because the stock is exhibiting an unusual behavior while displaying negative price action. In this case, the stock crossed an important inflection point; namely, "support" while at the same time the range of the stock's movement in price is twice its normal size. This large range foreshadows a possible continuation as the stock moves lower. EXCLUSIVE OFFER: Get the inside scoop on opportunities in OHI with the Ticky from Trade-Ideas. See the FREE profile for OHI NOW at Trade-Ideas More details on OHI: Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. The stock currently has a dividend yield of 6.2%. OHI has a PE ratio of 25. Currently there are 4 analysts that rate Omega Healthcare Investors a buy, 2 analysts rate it a sell, and 2 rate it a hold. The average volume for Omega Healthcare Investors has been 1.4 million shares per day over the past 30 days. Omega Healthcare Investors has a market cap of $6.7 billion and is part of the financial sector and real estate industry. The stock has a beta of 0.53 and a short float of 3.5% with 4.44 days to cover. Shares are down 7.4% year-to-date as of the close of trading on Tuesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates Omega Healthcare Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Highlights from the ratings report include:
- OHI's very impressive revenue growth greatly exceeded the industry average of 9.8%. Since the same quarter one year prior, revenues leaped by 62.3%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
- Net operating cash flow has slightly increased to $89.80 million or 1.23% when compared to the same quarter last year. Despite an increase in cash flow, OMEGA HEALTHCARE INVS INC's cash flow growth rate is still lower than the industry average growth rate of 13.29%.
- The gross profit margin for OMEGA HEALTHCARE INVS INC is rather high; currently it is at 66.59%. Regardless of OHI's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 20.95% trails the industry average.
- OMEGA HEALTHCARE INVS INC's earnings per share declined by 40.5% in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. We feel it is likely to report a decline in earnings in the coming year. During the past fiscal year, OMEGA HEALTHCARE INVS INC increased its bottom line by earning $1.74 versus $1.46 in the prior year. For the next year, the market is expecting a contraction of 24.1% in earnings ($1.32 versus $1.74).
- In its most recent trading session, OHI has closed at a price level that was not very different from its closing price of one year earlier. This is probably due to its weak earnings growth as well as other mixed factors. Looking ahead, although the push and pull of the overall market trend could certainly make a critical difference, we do not see any strong reason stemming from the company's fundamentals that would cause a continuation of last year's decline. In fact, the stock is now selling for less than others in its industry in relation to its current earnings.
- You can view the full Omega Healthcare Investors Ratings Report.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.